ANIP vs CUBE · rev $614.4M vs P/E 25, rev $1.07B
ANI Pharmaceuticals Inc (ANIP) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ANIP revenue for 2024-12-31 was $614.4M. Net income was -$18.5M. Revenue was up 26.2% from 2023-12-31 to 2024-12-31. ANIP currently screens at market cap $1.41B.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ANIP currently screens at market cap $1.41B. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ANIP and CUBE stock pages for the full models.
Not investment advice.